Sun Pharma Shareholders Approve ESOP 2026, Enhanced Borrowing, and Investment Limits
Sun Pharmaceutical Industries Ltd 路 Others (Uncategorized) 路 01 Nov 2026, 1:44 am
Sun Pharma Shareholders Approve ESOP 2026, Enhanced Borrowing, and Investment Limits Sun Pharmaceutical Industries announced the approval of all special resolutions via postal ballot concluded on 31st Oct'26. Shareholders approved the Sun Pharma Employees Stock Option Plan 2026 ("ESOP 2026"), including trust funding, secondary share acquisitions, and scheme extension to subsidiary employees. Additionally, members cleared key capital-structuring resolutions, including enhanced investment and lending limits under Section 186, expanded borrowing limits under Section 180(1)(c), creation of security under Section 180(1)(a) of the Companies Act, 2013, and creation of encumbrances over shares pursuant to SEBI Listing Regulations.
Original exchange filing (PDF)
More announcements from Sun Pharmaceutical Industries Ltd
- Intimation of Schedule of Analyst/Institutional Investor Meeting 路 05 Nov 2026
- Q2FY27 Earnings Call Transcript 路 05 Nov 2026
- Clarification regarding news report relating to the Company''s Assam facility 路 03 Nov 2026
- The Exchange has sought clarification from Sun Pharmaceutical Industries Ltd on November 2, 2026, with reference to news appeared in https://www.thehindu.com/ dated October 30, 2026 quoting .... 路 02 Nov 2026
- Q2FY27- Investor Call Audio Recording 路 31 Oct 2026
- Board Meeting Outcome - Conclusion 路 30 Oct 2026
- Unaudited Financial Results for the quarter and half year ended 30 September 2026 路 30 Oct 2026
- Unaudited Financial Results for the quarter and half year ended 30 September 2026 路 30 Oct 2026
